References
American Academy of Pediatrics Committee on Infectious Diseases. (2014)Updated Guidance for Palivizumab Prophylaxis Among Infants and
Young Children at Increased Risk of Hospitalization for Respiratory
Syncytial Virus Infection. [Versión electrónica].Pediatrics,
134(2):e620-38. Doi: 10.1542/peds.2014-1666.
Brady, M., Byington, C., Davies, H., Edwards, K., Jackson, M.,
Maldonado, Y.(2014). Updated Guidance for Palivizumab Prophylaxis
Among Infants and Young Children at Increased Risk of Hospitalization
for Respiratory Syncytial Virus Infection. [Versión electrónica].
Pediatrics, 134(2), e620-38. Doi: 10.1542/peds.2014-1666.
Carande, E., Pollard, A., Drysdale, S. (2016). Management of
respiratory syncytial virus bronchiolitis: 2015 survey of members of the
European Society for Paediatric Infectious Diseases . [Versión
electrónica]. The Canadian journal of infectious diseases &
medical microbiology = Journal canadien des maladies infectieuses et de
la microbiologie medicale, 2016, 919139537. Doi: 10.1155/2016/9139537
Diagnóstico y tratamiento de bronquiolitis aguda en niñas/niños y en el
primer nivel de atención. Guía de evidencias y recomendaciones: Guía de
práctica clínica. México, Cenetec; 2015 (consultada el 31 de octubre de
2019). Disponible en:
http://www.cenetec.salud.gob.mx/interior/catalogoMaestroGPC.html
Pamela P., Carneiro M., (2017). Immunology of breast milk.[Versión electrónica]. Rev Assoc Med Bras (1992). 2016
Sep;62(6):584-593. doi: 10.1590/1806-9282.62.06.584.
Hashimoto K, Hosoya M. (2017). Neutralizing epitopes of RSV and
palivizumab resistance in Japan . [Versión electrónica]. Fukushima J
Med Sci. 2017 Dec 19;63(3):127-134. doi: 10.5387/fms.2017-09. Epub 2017
Sep.
Falsey, A., Koval, C., DeVincenzo J., Walsh, E. (2017).
Compassionate use experience with
high-titer respiratory syncytical virus (RSV) immunoglobulin in
RSV-infected immunocompromised persons . [Versión
electrónica].Transplant infectious disease: an official journal of the
Transplantation Society, 19(2), 1-8. Doi: 10.1111/tid.12657.
Gamiño-Arroyo, A., Moreno-Espinosa S., Llamosas-Gallardo
B, Ortiz-Hernández A, Guerrero M, Galindo-Fraga A., et al. (2017).Epidemiology and clinical characteristics of respiratory syncytial
virus infections among children and adults in Mexico . [Versión
electrónica]. Influenza and other respiratory viruses, 11(1), 48-56.
Doi: 10.1111/irv.12414.
Hui, D., Rossi, G., Johnston, S. (2016). SARS, MERS and other
Viral Lung Infections. European Respiratory Society
publications. 72, 84-109. Doi: 10.1183/2312508X.erm7216
Jans, J., Wicht, O., Widjaja, L., Ahout, L., de Groot, R., Guichelaar,
T., et al. (2017). Characteristics of RSV-Specific Maternal
Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three
Months of Age. [Versión electrónica].PLoS
One,12(1):e0170877.Doi.org/10.1371/journal.pone.0170877
Javelle, E., Colson, P., Parola, P., Raoult, D. (2019). Measles,
the need for a paradigm shift . [Versión electrónica]. European
journal of epidemiology, 1573-7284. Doi: 10.1007/s10654-019-00569-4.
Jounai, N., Yoshioka, M., Tozuka, M., Inoue, K., Oka, T., Miyaji, K., et
al. (2017). Age-Specific Profiles of Antibody Responses against
Respiratory Syncytial Virus Infection . [Versión
electrónica].EBioMedicine, 16 , 124–135.
Doi:10.1016/j.ebiom.2017.01.014.
Lee, N., Qureshi, S. (2013). Other Viral Pneumonias Coronavirus,
Respiratory Syncytial Virus, Adenovirus, Hantavirus. [Versión
electrónica]. Critical care clinics, 29(4), 1045-1068. Doi:
10.1016/j.ccc.2013.07.003
Liu, W., Chen, D., Tan, W., Xu, D., Qiu, S., Zeng, Z., et al. (2016).
Epidemiology and Clinical Presentations of Respiratory Syncytial Virus
Subgroups A and B Detected with Multiplex Real Time PCR. [Versión
electrónica]. PLoS One, 11(10), e0165108. Doi:
10.1371/journal.pone.0165108.
Lukšić, I., Kearns, P., K., Scott, F., Rudan, I., Campbell, H., Nair, H.
(2013).Viral etiology of hospitalized acute lower respiratory
infections in children under 5 years of age – a systematic review and
meta-analysis. . [Versión electrónica]. Croatian medical
journal, 54(2), 122–134. Doi:10.3325/cmj.2013.54.122
Mazur, N., Horsley, N., Englund, J., Nederend, M., Magaret, Kumar A., et
al. (2019). Breast Milk Prefusion F Immunoglobulin G as a
Correlate of Protection
Against Respiratory Syncytial Virus Acute Respiratory Illness .
[Versión electrónica]. The journal of infectious diseases, 219(1),
59-67. Doi: 10.1093/infdis/jiy477.
Noor, A., Krilov, L. (2018). Respiratory syncytial virus vaccine:
where are we now and what comes next? [Versión electrónica]. Expert
opinion on biological therapy,18(12), 1247-1256. Doi:
10.1080/14712598.2018.1544239
Nyiro, J., Sande, C., Mutunga, M., Kiyuka, P., Munywoki, P., Scott, J.,
et al. (2016). Absence of Association between Cord Specific
Antibody Levels and Severe Respiratory Syncytial Virus (RSV) Disease in
Early Infants: A Case Control Study from Coastal Kenya. [Versión
electrónica].PLoS One, 11(11), e0166706. Doi:
10.1371/journal.pone.0166706.
Patel, K., Kirkpatrick C., Nieforth, K., Chanda, S., Zhang, Q., McClure,
M., et al. (2019). Respiratory syncytial virus-A dynamics and the
effects of lumicitabine, a nucleoside viral replication inhibitor, in
experimentally infected humans. [Versión electrónica]. The journal
of antimicrobial chemotherapy, 74(2), 442-452. Doi: 10.1093/jac/dky415.
Palmeira, P., Carneiro-Sampaio, M. (2016). Immunology of breast
milk . [Versión electrónica]. Revista da Associação Médica
Brasileira, 62(6), 584-593. Doi: 10.1590/1806-9282.62.06.584.
Piedimonte, G. (2015). RSV infections: State of the art.[Versión electrónica]. Cleveland Clinic journal of medicine, 82 (11
Suppl 1). Doi: 10.3949/ccjm.82.s1.03
Robledo-Aceves, M., Moreno-Peregrina, M., Velarde-Rivera, F.,
Ascencio-Esparza, E., Preciado-Figueroa, F., Caniza, M., et al. (2018).Risk factors for severe bronchiolitis caused by respiratory virus
infections among Mexican children in an emergency department.[Versión electrónica]Medicine, 97(9), e0057. Doi:
10.1097/MD.0000000000010057.
Sakaguchi, K., Koyanagi. A., Kamachi, F., Harauma, A., Chiba, A.,
Hisata, K., et al. (2018). Breastfeeding regulates development of
immune system through TGF-β in mice pups. [Versión electrónica].
Pediatrics international: official journal of the Japan Pediatric
Society, 60(3):224-231. Doi: 10.1111/ped.13507.
Simões, E., Bont, L., Manzoni, P., Fauroux, B., Paes, B., Figueras-Aloy,
J., et. al. (2018). Past, Present and Future Approaches to the
Prevention and Treatment of Respiratory Syncytial Virus Infection in
Children . [Versión electrónica]. Infectious diseases and therapy,
7(1), 87–120. Doi: 10.1007/s40121-018-0188-z.
Shay, A., Holman, R., Newman, R., Liu, L., Stout, J., Anderson, L.
(1999). Bronchiolitis-associated hospitalizations among US
children, 1980-1996. [Versión electrónica]. The Journal of the
American Medical Association, 282(15), 1440-6. DOI:
10.1001/jama.282.15.1440.
Shi T., David A McAllister, D., O’Brien, K., Simoes, E., Madhi, S.,
Gessner, B. (2017). Global, regional, and national disease burden
estimates of acute lower respiratory infections due to respiratory
syncytial virus in young children in 2015: a systematic review and
modelling study. [Versión electrónica]. Lancet, 390 (10098),
946–958.
Vissers, M., Ahout, I.,de Jonge, M., Ferwerda, G. (2016). Mucosal
IgG Levels Correlate Better with Respiratory Syncytial Virus Load and
Inflammation than Plasma IgG Levels. [Versión electrónica].Clinical
and vaccine immunology, 23(3), 243-245. Doi: 10.1128/CVI.00590-15.
Walsh, E., Wang, L., Falsey, A., Qiu, X., Corbett, A., Holden-Wiltse,
J., et al. (2018).Virus-Specific Antibody, Viral Load, and Disease
Severity in Respiratory Syncytial Virus Infection. [Versión
electrónica].The journal of infectious diseases, 218(2), 208-217. Doi:
10.1093/infdis/jiy106.
Xing, Y., Proesmans, M. (2019).New therapies for acute RSV
infections: where are we? [Versión electrónica].European journal of
pediatrics, 178(2),131-138.